This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • Longitudinal B-type natriuretic peptide monitoring and kidney failure

  • Serum potassium and risk of death or kidney replacement therapy in older patients with advanced CKD

  • Low and high potassium levels associated with harm in older people with chronic kidney disease

  • Digital physical activity and emotional well-being intervention: Kidney BEAM trial design and baseline data

  • Chronic kidney disease and incident heart failure: insights from the Atherosclerosis Risk in Communities study

  • The safety of sodium–glucose cotransporter-2 inhibitors in people with chronic kidney disease and type 2 diabetes

    The safety of sodium–glucose cotransporter-2 inhibitors in people with chronic kidney disease and type 2 diabetes

  • Apixaban vs warfarin in patients with nonvalvular atrial fibrillation receiving dialysis

    Apixaban vs warfarin in patients with nonvalvular atrial fibrillation receiving dialysis

  • Hypoxia-inducible factor prolyl- hydroxylase inhibitors for anaemia in patients with chronic kidney disease: Analysis of adverse events

    Hypoxia-inducible factor prolyl- hydroxylase inhibitors for anaemia in patients with chronic kidney disease: Analysis of adverse events

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe